Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective

Title
Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective
Authors
Keywords
clinical pharmacology assessment, immunogenicity data for approved biological products, impact on clinical pharmacokinetics and efficacy, incidence of anti-drug antibodies and neutralizing antibodies
Journal
AAPS Journal
Volume 18, Issue 2, Pages 395-403
Publisher
American Association of Pharmaceutical Scientists (AAPS)
Online
2016-01-01
DOI
10.1208/s12248-015-9857-y

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started